Global Novel Oral AntiCoagulants (NOAC) Supply, Demand and Key Producers, 2023-2029

Page: 116

Published Date: 17 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

This report studies the global Novel Oral AntiCoagulants (NOAC) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Novel Oral AntiCoagulants (NOAC), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Novel Oral AntiCoagulants (NOAC) that contribute to its increasing demand across many markets.

The global Novel Oral AntiCoagulants (NOAC) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.

North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

Highlights and key features of the study
Global Novel Oral AntiCoagulants (NOAC) total production and demand, 2018-2029, (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) total production value, 2018-2029, (USD Million)
Global Novel Oral AntiCoagulants (NOAC) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) consumption by region & country, CAGR, 2018-2029 & (K Pcs)
U.S. VS China: Novel Oral AntiCoagulants (NOAC) domestic production, consumption, key domestic manufacturers and share
Global Novel Oral AntiCoagulants (NOAC) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
Global Novel Oral AntiCoagulants (NOAC) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Pcs)
This reports profiles key players in the global Novel Oral AntiCoagulants (NOAC) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, Daiichi Sankyo, Armatheon, Aspen, AstraZeneca and Bayer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Novel Oral AntiCoagulants (NOAC) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Novel Oral AntiCoagulants (NOAC) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Novel Oral AntiCoagulants (NOAC) Market, Segmentation by Type
    Direct Thrombin Inhibitors
    Direct Factor Xa Inhibitors

Global Novel Oral AntiCoagulants (NOAC) Market, Segmentation by Application
    Deep Vein Thrombosis (DVT)
    Pulmonary Embolism
    Acute Coronary Syndrome
    Hemodialysis
    Others

Companies Profiled:
    Johnson & Johnson
    Bristol-Myers Squibb
    Boehringer Ingelheim
    Sanofi
    Daiichi Sankyo
    Armatheon
    Aspen
    AstraZeneca
    Bayer
    Cellceutix
    Cosmo Pharmaceuticals
    CSL Behring
    Eisai
    GSK
    Marathon Pharmaceuticals
    Ockham Biotech
    Perosphere

Key Questions Answered
1. How big is the global Novel Oral AntiCoagulants (NOAC) market?
2. What is the demand of the global Novel Oral AntiCoagulants (NOAC) market?
3. What is the year over year growth of the global Novel Oral AntiCoagulants (NOAC) market?
4. What is the production and production value of the global Novel Oral AntiCoagulants (NOAC) market?
5. Who are the key producers in the global Novel Oral AntiCoagulants (NOAC) market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Novel Oral AntiCoagulants (NOAC) Introduction
    1.2 World Novel Oral AntiCoagulants (NOAC) Supply & Forecast
        1.2.1 World Novel Oral AntiCoagulants (NOAC) Production Value (2018 & 2022 & 2029)
        1.2.2 World Novel Oral AntiCoagulants (NOAC) Production (2018-2029)
        1.2.3 World Novel Oral AntiCoagulants (NOAC) Pricing Trends (2018-2029)
    1.3 World Novel Oral AntiCoagulants (NOAC) Production by Region (Based on Production Site)
        1.3.1 World Novel Oral AntiCoagulants (NOAC) Production Value by Region (2018-2029)
        1.3.2 World Novel Oral AntiCoagulants (NOAC) Production by Region (2018-2029)
        1.3.3 World Novel Oral AntiCoagulants (NOAC) Average Price by Region (2018-2029)
        1.3.4 North America Novel Oral AntiCoagulants (NOAC) Production (2018-2029)
        1.3.5 Europe Novel Oral AntiCoagulants (NOAC) Production (2018-2029)
        1.3.6 China Novel Oral AntiCoagulants (NOAC) Production (2018-2029)
        1.3.7 Japan Novel Oral AntiCoagulants (NOAC) Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Novel Oral AntiCoagulants (NOAC) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Novel Oral AntiCoagulants (NOAC) Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Novel Oral AntiCoagulants (NOAC) Demand (2018-2029)
    2.2 World Novel Oral AntiCoagulants (NOAC) Consumption by Region
        2.2.1 World Novel Oral AntiCoagulants (NOAC) Consumption by Region (2018-2023)
        2.2.2 World Novel Oral AntiCoagulants (NOAC) Consumption Forecast by Region (2024-2029)
    2.3 United States Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029)
    2.4 China Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029)
    2.5 Europe Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029)
    2.6 Japan Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029)
    2.7 South Korea Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029)
    2.8 ASEAN Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029)
    2.9 India Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029)

3 World Novel Oral AntiCoagulants (NOAC) Manufacturers Competitive Analysis
    3.1 World Novel Oral AntiCoagulants (NOAC) Production Value by Manufacturer (2018-2023)
    3.2 World Novel Oral AntiCoagulants (NOAC) Production by Manufacturer (2018-2023)
    3.3 World Novel Oral AntiCoagulants (NOAC) Average Price by Manufacturer (2018-2023)
    3.4 Novel Oral AntiCoagulants (NOAC) Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Novel Oral AntiCoagulants (NOAC) Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Novel Oral AntiCoagulants (NOAC) in 2022
        3.5.3 Global Concentration Ratios (CR8) for Novel Oral AntiCoagulants (NOAC) in 2022
    3.6 Novel Oral AntiCoagulants (NOAC) Market: Overall Company Footprint Analysis
        3.6.1 Novel Oral AntiCoagulants (NOAC) Market: Region Footprint
        3.6.2 Novel Oral AntiCoagulants (NOAC) Market: Company Product Type Footprint
        3.6.3 Novel Oral AntiCoagulants (NOAC) Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Novel Oral AntiCoagulants (NOAC) Production Value Comparison
        4.1.1 United States VS China: Novel Oral AntiCoagulants (NOAC) Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Novel Oral AntiCoagulants (NOAC) Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Novel Oral AntiCoagulants (NOAC) Production Comparison
        4.2.1 United States VS China: Novel Oral AntiCoagulants (NOAC) Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Novel Oral AntiCoagulants (NOAC) Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Novel Oral AntiCoagulants (NOAC) Consumption Comparison
        4.3.1 United States VS China: Novel Oral AntiCoagulants (NOAC) Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Novel Oral AntiCoagulants (NOAC) Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Novel Oral AntiCoagulants (NOAC) Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Novel Oral AntiCoagulants (NOAC) Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production (2018-2023)
    4.5 China Based Novel Oral AntiCoagulants (NOAC) Manufacturers and Market Share
        4.5.1 China Based Novel Oral AntiCoagulants (NOAC) Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Value (2018-2023)
        4.5.3 China Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production (2018-2023)
    4.6 Rest of World Based Novel Oral AntiCoagulants (NOAC) Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Novel Oral AntiCoagulants (NOAC) Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production (2018-2023)

5 Market Analysis by Type
    5.1 World Novel Oral AntiCoagulants (NOAC) Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Direct Thrombin Inhibitors
        5.2.2 Direct Factor Xa Inhibitors
    5.3 Market Segment by Type
        5.3.1 World Novel Oral AntiCoagulants (NOAC) Production by Type (2018-2029)
        5.3.2 World Novel Oral AntiCoagulants (NOAC) Production Value by Type (2018-2029)
        5.3.3 World Novel Oral AntiCoagulants (NOAC) Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Novel Oral AntiCoagulants (NOAC) Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Deep Vein Thrombosis (DVT)
        6.2.2 Pulmonary Embolism
        6.2.3 Acute Coronary Syndrome
        6.2.4 Hemodialysis
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Novel Oral AntiCoagulants (NOAC) Production by Application (2018-2029)
        6.3.2 World Novel Oral AntiCoagulants (NOAC) Production Value by Application (2018-2029)
        6.3.3 World Novel Oral AntiCoagulants (NOAC) Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Details
        7.1.2 Johnson & Johnson Major Business
        7.1.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Product and Services
        7.1.4 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Johnson & Johnson Recent Developments/Updates
        7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.2 Bristol-Myers Squibb
        7.2.1 Bristol-Myers Squibb Details
        7.2.2 Bristol-Myers Squibb Major Business
        7.2.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Product and Services
        7.2.4 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Bristol-Myers Squibb Recent Developments/Updates
        7.2.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.3 Boehringer Ingelheim
        7.3.1 Boehringer Ingelheim Details
        7.3.2 Boehringer Ingelheim Major Business
        7.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Product and Services
        7.3.4 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Boehringer Ingelheim Recent Developments/Updates
        7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.4 Sanofi
        7.4.1 Sanofi Details
        7.4.2 Sanofi Major Business
        7.4.3 Sanofi Novel Oral AntiCoagulants (NOAC) Product and Services
        7.4.4 Sanofi Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Sanofi Recent Developments/Updates
        7.4.6 Sanofi Competitive Strengths & Weaknesses
    7.5 Daiichi Sankyo
        7.5.1 Daiichi Sankyo Details
        7.5.2 Daiichi Sankyo Major Business
        7.5.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Product and Services
        7.5.4 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Daiichi Sankyo Recent Developments/Updates
        7.5.6 Daiichi Sankyo Competitive Strengths & Weaknesses
    7.6 Armatheon
        7.6.1 Armatheon Details
        7.6.2 Armatheon Major Business
        7.6.3 Armatheon Novel Oral AntiCoagulants (NOAC) Product and Services
        7.6.4 Armatheon Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Armatheon Recent Developments/Updates
        7.6.6 Armatheon Competitive Strengths & Weaknesses
    7.7 Aspen
        7.7.1 Aspen Details
        7.7.2 Aspen Major Business
        7.7.3 Aspen Novel Oral AntiCoagulants (NOAC) Product and Services
        7.7.4 Aspen Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Aspen Recent Developments/Updates
        7.7.6 Aspen Competitive Strengths & Weaknesses
    7.8 AstraZeneca
        7.8.1 AstraZeneca Details
        7.8.2 AstraZeneca Major Business
        7.8.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Product and Services
        7.8.4 AstraZeneca Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 AstraZeneca Recent Developments/Updates
        7.8.6 AstraZeneca Competitive Strengths & Weaknesses
    7.9 Bayer
        7.9.1 Bayer Details
        7.9.2 Bayer Major Business
        7.9.3 Bayer Novel Oral AntiCoagulants (NOAC) Product and Services
        7.9.4 Bayer Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Bayer Recent Developments/Updates
        7.9.6 Bayer Competitive Strengths & Weaknesses
    7.10 Cellceutix
        7.10.1 Cellceutix Details
        7.10.2 Cellceutix Major Business
        7.10.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Product and Services
        7.10.4 Cellceutix Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Cellceutix Recent Developments/Updates
        7.10.6 Cellceutix Competitive Strengths & Weaknesses
    7.11 Cosmo Pharmaceuticals
        7.11.1 Cosmo Pharmaceuticals Details
        7.11.2 Cosmo Pharmaceuticals Major Business
        7.11.3 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product and Services
        7.11.4 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Cosmo Pharmaceuticals Recent Developments/Updates
        7.11.6 Cosmo Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 CSL Behring
        7.12.1 CSL Behring Details
        7.12.2 CSL Behring Major Business
        7.12.3 CSL Behring Novel Oral AntiCoagulants (NOAC) Product and Services
        7.12.4 CSL Behring Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 CSL Behring Recent Developments/Updates
        7.12.6 CSL Behring Competitive Strengths & Weaknesses
    7.13 Eisai
        7.13.1 Eisai Details
        7.13.2 Eisai Major Business
        7.13.3 Eisai Novel Oral AntiCoagulants (NOAC) Product and Services
        7.13.4 Eisai Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Eisai Recent Developments/Updates
        7.13.6 Eisai Competitive Strengths & Weaknesses
    7.14 GSK
        7.14.1 GSK Details
        7.14.2 GSK Major Business
        7.14.3 GSK Novel Oral AntiCoagulants (NOAC) Product and Services
        7.14.4 GSK Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 GSK Recent Developments/Updates
        7.14.6 GSK Competitive Strengths & Weaknesses
    7.15 Marathon Pharmaceuticals
        7.15.1 Marathon Pharmaceuticals Details
        7.15.2 Marathon Pharmaceuticals Major Business
        7.15.3 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product and Services
        7.15.4 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Marathon Pharmaceuticals Recent Developments/Updates
        7.15.6 Marathon Pharmaceuticals Competitive Strengths & Weaknesses
    7.16 Ockham Biotech
        7.16.1 Ockham Biotech Details
        7.16.2 Ockham Biotech Major Business
        7.16.3 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Product and Services
        7.16.4 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Ockham Biotech Recent Developments/Updates
        7.16.6 Ockham Biotech Competitive Strengths & Weaknesses
    7.17 Perosphere
        7.17.1 Perosphere Details
        7.17.2 Perosphere Major Business
        7.17.3 Perosphere Novel Oral AntiCoagulants (NOAC) Product and Services
        7.17.4 Perosphere Novel Oral AntiCoagulants (NOAC) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Perosphere Recent Developments/Updates
        7.17.6 Perosphere Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Novel Oral AntiCoagulants (NOAC) Industry Chain
    8.2 Novel Oral AntiCoagulants (NOAC) Upstream Analysis
        8.2.1 Novel Oral AntiCoagulants (NOAC) Core Raw Materials
        8.2.2 Main Manufacturers of Novel Oral AntiCoagulants (NOAC) Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Novel Oral AntiCoagulants (NOAC) Production Mode
    8.6 Novel Oral AntiCoagulants (NOAC) Procurement Model
    8.7 Novel Oral AntiCoagulants (NOAC) Industry Sales Model and Sales Channels
        8.7.1 Novel Oral AntiCoagulants (NOAC) Sales Model
        8.7.2 Novel Oral AntiCoagulants (NOAC) Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Novel Oral AntiCoagulants (NOAC) Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Novel Oral AntiCoagulants (NOAC) Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Novel Oral AntiCoagulants (NOAC) Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Novel Oral AntiCoagulants (NOAC) Production Value Market Share by Region (2018-2023)
    Table 5. World Novel Oral AntiCoagulants (NOAC) Production Value Market Share by Region (2024-2029)
    Table 6. World Novel Oral AntiCoagulants (NOAC) Production by Region (2018-2023) & (K Pcs)
    Table 7. World Novel Oral AntiCoagulants (NOAC) Production by Region (2024-2029) & (K Pcs)
    Table 8. World Novel Oral AntiCoagulants (NOAC) Production Market Share by Region (2018-2023)
    Table 9. World Novel Oral AntiCoagulants (NOAC) Production Market Share by Region (2024-2029)
    Table 10. World Novel Oral AntiCoagulants (NOAC) Average Price by Region (2018-2023) & (USD/Pcs)
    Table 11. World Novel Oral AntiCoagulants (NOAC) Average Price by Region (2024-2029) & (USD/Pcs)
    Table 12. Novel Oral AntiCoagulants (NOAC) Major Market Trends
    Table 13. World Novel Oral AntiCoagulants (NOAC) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Pcs)
    Table 14. World Novel Oral AntiCoagulants (NOAC) Consumption by Region (2018-2023) & (K Pcs)
    Table 15. World Novel Oral AntiCoagulants (NOAC) Consumption Forecast by Region (2024-2029) & (K Pcs)
    Table 16. World Novel Oral AntiCoagulants (NOAC) Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Novel Oral AntiCoagulants (NOAC) Producers in 2022
    Table 18. World Novel Oral AntiCoagulants (NOAC) Production by Manufacturer (2018-2023) & (K Pcs)
    Table 19. Production Market Share of Key Novel Oral AntiCoagulants (NOAC) Producers in 2022
    Table 20. World Novel Oral AntiCoagulants (NOAC) Average Price by Manufacturer (2018-2023) & (USD/Pcs)
    Table 21. Global Novel Oral AntiCoagulants (NOAC) Company Evaluation Quadrant
    Table 22. World Novel Oral AntiCoagulants (NOAC) Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Novel Oral AntiCoagulants (NOAC) Production Site of Key Manufacturer
    Table 24. Novel Oral AntiCoagulants (NOAC) Market: Company Product Type Footprint
    Table 25. Novel Oral AntiCoagulants (NOAC) Market: Company Product Application Footprint
    Table 26. Novel Oral AntiCoagulants (NOAC) Competitive Factors
    Table 27. Novel Oral AntiCoagulants (NOAC) New Entrant and Capacity Expansion Plans
    Table 28. Novel Oral AntiCoagulants (NOAC) Mergers & Acquisitions Activity
    Table 29. United States VS China Novel Oral AntiCoagulants (NOAC) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Novel Oral AntiCoagulants (NOAC) Production Comparison, (2018 & 2022 & 2029) & (K Pcs)
    Table 31. United States VS China Novel Oral AntiCoagulants (NOAC) Consumption Comparison, (2018 & 2022 & 2029) & (K Pcs)
    Table 32. United States Based Novel Oral AntiCoagulants (NOAC) Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production (2018-2023) & (K Pcs)
    Table 36. United States Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Market Share (2018-2023)
    Table 37. China Based Novel Oral AntiCoagulants (NOAC) Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production (2018-2023) & (K Pcs)
    Table 41. China Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Market Share (2018-2023)
    Table 42. Rest of World Based Novel Oral AntiCoagulants (NOAC) Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production (2018-2023) & (K Pcs)
    Table 46. Rest of World Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Market Share (2018-2023)
    Table 47. World Novel Oral AntiCoagulants (NOAC) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Novel Oral AntiCoagulants (NOAC) Production by Type (2018-2023) & (K Pcs)
    Table 49. World Novel Oral AntiCoagulants (NOAC) Production by Type (2024-2029) & (K Pcs)
    Table 50. World Novel Oral AntiCoagulants (NOAC) Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Novel Oral AntiCoagulants (NOAC) Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Novel Oral AntiCoagulants (NOAC) Average Price by Type (2018-2023) & (USD/Pcs)
    Table 53. World Novel Oral AntiCoagulants (NOAC) Average Price by Type (2024-2029) & (USD/Pcs)
    Table 54. World Novel Oral AntiCoagulants (NOAC) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Novel Oral AntiCoagulants (NOAC) Production by Application (2018-2023) & (K Pcs)
    Table 56. World Novel Oral AntiCoagulants (NOAC) Production by Application (2024-2029) & (K Pcs)
    Table 57. World Novel Oral AntiCoagulants (NOAC) Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Novel Oral AntiCoagulants (NOAC) Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Novel Oral AntiCoagulants (NOAC) Average Price by Application (2018-2023) & (USD/Pcs)
    Table 60. World Novel Oral AntiCoagulants (NOAC) Average Price by Application (2024-2029) & (USD/Pcs)
    Table 61. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 62. Johnson & Johnson Major Business
    Table 63. Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 64. Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Johnson & Johnson Recent Developments/Updates
    Table 66. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 67. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 68. Bristol-Myers Squibb Major Business
    Table 69. Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 70. Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Bristol-Myers Squibb Recent Developments/Updates
    Table 72. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 73. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 74. Boehringer Ingelheim Major Business
    Table 75. Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 76. Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Boehringer Ingelheim Recent Developments/Updates
    Table 78. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 80. Sanofi Major Business
    Table 81. Sanofi Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 82. Sanofi Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Sanofi Recent Developments/Updates
    Table 84. Sanofi Competitive Strengths & Weaknesses
    Table 85. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
    Table 86. Daiichi Sankyo Major Business
    Table 87. Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 88. Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Daiichi Sankyo Recent Developments/Updates
    Table 90. Daiichi Sankyo Competitive Strengths & Weaknesses
    Table 91. Armatheon Basic Information, Manufacturing Base and Competitors
    Table 92. Armatheon Major Business
    Table 93. Armatheon Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 94. Armatheon Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Armatheon Recent Developments/Updates
    Table 96. Armatheon Competitive Strengths & Weaknesses
    Table 97. Aspen Basic Information, Manufacturing Base and Competitors
    Table 98. Aspen Major Business
    Table 99. Aspen Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 100. Aspen Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Aspen Recent Developments/Updates
    Table 102. Aspen Competitive Strengths & Weaknesses
    Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 104. AstraZeneca Major Business
    Table 105. AstraZeneca Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 106. AstraZeneca Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. AstraZeneca Recent Developments/Updates
    Table 108. AstraZeneca Competitive Strengths & Weaknesses
    Table 109. Bayer Basic Information, Manufacturing Base and Competitors
    Table 110. Bayer Major Business
    Table 111. Bayer Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 112. Bayer Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Bayer Recent Developments/Updates
    Table 114. Bayer Competitive Strengths & Weaknesses
    Table 115. Cellceutix Basic Information, Manufacturing Base and Competitors
    Table 116. Cellceutix Major Business
    Table 117. Cellceutix Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 118. Cellceutix Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Cellceutix Recent Developments/Updates
    Table 120. Cellceutix Competitive Strengths & Weaknesses
    Table 121. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 122. Cosmo Pharmaceuticals Major Business
    Table 123. Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 124. Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Cosmo Pharmaceuticals Recent Developments/Updates
    Table 126. Cosmo Pharmaceuticals Competitive Strengths & Weaknesses
    Table 127. CSL Behring Basic Information, Manufacturing Base and Competitors
    Table 128. CSL Behring Major Business
    Table 129. CSL Behring Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 130. CSL Behring Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. CSL Behring Recent Developments/Updates
    Table 132. CSL Behring Competitive Strengths & Weaknesses
    Table 133. Eisai Basic Information, Manufacturing Base and Competitors
    Table 134. Eisai Major Business
    Table 135. Eisai Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 136. Eisai Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Eisai Recent Developments/Updates
    Table 138. Eisai Competitive Strengths & Weaknesses
    Table 139. GSK Basic Information, Manufacturing Base and Competitors
    Table 140. GSK Major Business
    Table 141. GSK Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 142. GSK Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. GSK Recent Developments/Updates
    Table 144. GSK Competitive Strengths & Weaknesses
    Table 145. Marathon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 146. Marathon Pharmaceuticals Major Business
    Table 147. Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 148. Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Marathon Pharmaceuticals Recent Developments/Updates
    Table 150. Marathon Pharmaceuticals Competitive Strengths & Weaknesses
    Table 151. Ockham Biotech Basic Information, Manufacturing Base and Competitors
    Table 152. Ockham Biotech Major Business
    Table 153. Ockham Biotech Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 154. Ockham Biotech Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Ockham Biotech Recent Developments/Updates
    Table 156. Perosphere Basic Information, Manufacturing Base and Competitors
    Table 157. Perosphere Major Business
    Table 158. Perosphere Novel Oral AntiCoagulants (NOAC) Product and Services
    Table 159. Perosphere Novel Oral AntiCoagulants (NOAC) Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 160. Global Key Players of Novel Oral AntiCoagulants (NOAC) Upstream (Raw Materials)
    Table 161. Novel Oral AntiCoagulants (NOAC) Typical Customers
    Table 162. Novel Oral AntiCoagulants (NOAC) Typical Distributors
List of Figure
    Figure 1. Novel Oral AntiCoagulants (NOAC) Picture
    Figure 2. World Novel Oral AntiCoagulants (NOAC) Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Novel Oral AntiCoagulants (NOAC) Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Novel Oral AntiCoagulants (NOAC) Production (2018-2029) & (K Pcs)
    Figure 5. World Novel Oral AntiCoagulants (NOAC) Average Price (2018-2029) & (USD/Pcs)
    Figure 6. World Novel Oral AntiCoagulants (NOAC) Production Value Market Share by Region (2018-2029)
    Figure 7. World Novel Oral AntiCoagulants (NOAC) Production Market Share by Region (2018-2029)
    Figure 8. North America Novel Oral AntiCoagulants (NOAC) Production (2018-2029) & (K Pcs)
    Figure 9. Europe Novel Oral AntiCoagulants (NOAC) Production (2018-2029) & (K Pcs)
    Figure 10. China Novel Oral AntiCoagulants (NOAC) Production (2018-2029) & (K Pcs)
    Figure 11. Japan Novel Oral AntiCoagulants (NOAC) Production (2018-2029) & (K Pcs)
    Figure 12. Novel Oral AntiCoagulants (NOAC) Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029) & (K Pcs)
    Figure 15. World Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Region (2018-2029)
    Figure 16. United States Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029) & (K Pcs)
    Figure 17. China Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029) & (K Pcs)
    Figure 18. Europe Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029) & (K Pcs)
    Figure 19. Japan Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029) & (K Pcs)
    Figure 20. South Korea Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029) & (K Pcs)
    Figure 21. ASEAN Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029) & (K Pcs)
    Figure 22. India Novel Oral AntiCoagulants (NOAC) Consumption (2018-2029) & (K Pcs)
    Figure 23. Producer Shipments of Novel Oral AntiCoagulants (NOAC) by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Novel Oral AntiCoagulants (NOAC) Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Novel Oral AntiCoagulants (NOAC) Markets in 2022
    Figure 26. United States VS China: Novel Oral AntiCoagulants (NOAC) Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Novel Oral AntiCoagulants (NOAC) Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Novel Oral AntiCoagulants (NOAC) Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Market Share 2022
    Figure 30. China Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Novel Oral AntiCoagulants (NOAC) Production Market Share 2022
    Figure 32. World Novel Oral AntiCoagulants (NOAC) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Novel Oral AntiCoagulants (NOAC) Production Value Market Share by Type in 2022
    Figure 34. Direct Thrombin Inhibitors
    Figure 35. Direct Factor Xa Inhibitors
    Figure 36. World Novel Oral AntiCoagulants (NOAC) Production Market Share by Type (2018-2029)
    Figure 37. World Novel Oral AntiCoagulants (NOAC) Production Value Market Share by Type (2018-2029)
    Figure 38. World Novel Oral AntiCoagulants (NOAC) Average Price by Type (2018-2029) & (USD/Pcs)
    Figure 39. World Novel Oral AntiCoagulants (NOAC) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Novel Oral AntiCoagulants (NOAC) Production Value Market Share by Application in 2022
    Figure 41. Deep Vein Thrombosis (DVT)
    Figure 42. Pulmonary Embolism
    Figure 43. Acute Coronary Syndrome
    Figure 44. Hemodialysis
    Figure 45. Others
    Figure 46. World Novel Oral AntiCoagulants (NOAC) Production Market Share by Application (2018-2029)
    Figure 47. World Novel Oral AntiCoagulants (NOAC) Production Value Market Share by Application (2018-2029)
    Figure 48. World Novel Oral AntiCoagulants (NOAC) Average Price by Application (2018-2029) & (USD/Pcs)
    Figure 49. Novel Oral AntiCoagulants (NOAC) Industry Chain
    Figure 50. Novel Oral AntiCoagulants (NOAC) Procurement Model
    Figure 51. Novel Oral AntiCoagulants (NOAC) Sales Model
    Figure 52. Novel Oral AntiCoagulants (NOAC) Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Novel Oral AntiCoagulants (NOAC) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Novel Oral AntiCoagulants (NOAC) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 25 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Novel Oral AntiCoagulants (NOAC) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Novel Oral AntiCoagulants (NOAC)

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>